| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 8 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | China | 5 | |
| #4 | United States | 5 | |
| #5 | South Africa | 5 | |
| #6 | Australia | 4 | |
| #7 | Canada | 3 | |
| #8 | EAPO (Eurasian Patent Organization) | 3 | |
| #9 | African Regional Industrial Property Organization | 2 | |
| #10 | Republic of Korea | 2 | |
| #11 | Mexico | 2 | |
| #12 | Ukraine | 2 | |
| #13 | Brazil | 1 | |
| #14 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies | |
| #6 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fleury Sylvain | 30 |
| #2 | Bomsel Morgane | 15 |
| #3 | Mouz Nicolas | 14 |
| #4 | Roger Marie-Gaelle | 12 |
| #5 | Zurbriggen Rinaldo | 9 |
| #6 | Sylvain Fleury | 4 |
| #7 | Marie-Gaelle Roger | 4 |
| #8 | Kienzl Ursula | 3 |
| #9 | Tudor Daniela | 3 |
| #10 | Serres Pierre-Francois | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2011128720A1 | Trans-activator of transcription protein | |
| UA106221C2 | Method for treatment of hiv | |
| EP2393510A1 | Novel gp41 antigens | |
| WO2007099387A1 | Virosome-like vesicles comprising gp41-derived antigens | |
| WO2006117586A1 | Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 | |
| ZA200709438B | Antibody or a fragment thereof, having neutralizing activity against HIV but not against IL2 | |
| WO2005010033A1 | New soluble and stabilized trimeric form of gp41 polypeptides | |
| CA2489050A1 | Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells | |
| WO03048187A2 | Peptides and use thereof in therapeutic agents against hiv infection |